Allied Specialist Hospital & Clinics
Abbottābād, Khyber PkahtoonKhwa, 22020, Pakistan
Location status: Recruiting
NCT Number: NCT07110116
To compare effects of Alternate Nostril Breathing exercise with incentive spirometer on lung functions (forced vital capacity, forced expiratory volume, and peak expiratory flow rate) in Asthma patients.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
Abbottābād, Khyber PkahtoonKhwa, 22020, Pakistan
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in experimental group were instructed to close their left nostril by left index finger and inhale through their right nostril for six seconds, then closing the right nostril and holding breath for six seconds. Afterward, they exhaled through the left nostril slowly for six seconds. Next, they inhaled through left nostril, keeping the right nostril closed for six seconds then hold the breath by closing both nostrils for six seconds subsequently, and then exhaled through the right nostril, keeping the left closed for six seconds repeating these steps several times for 10 minutes
The control group participants were asked to do breathing exercise with incentive spirometry. The subject is asked to create a tight seal around the mouthpiece and asked to inhale deeply and slowly and the subject would observe the flow meter for visual feedback of his/her effort. At the end of the inspiration the subject is asked to sustain the inhalation 2-3 seconds to facilitate the Inspiratory hold. Subject relaxes the seal around the mouthpiece and exhales. Normal breathing is taken, then the exhalation phase in the incentive spirometry is done and the whole cycle is repeated 5 - 10 times thrice a day over a period 6 weeks
Time frame: 6 week
Forced Expiratory Volume in 1 second (FEV1) is a measurement of how much air a person can forcefully exhale from their lungs in one second
Time frame: 6 week
Forced vital capacity (FVC) is a measurement of lung function that quantifies the maximum amount of air a person can forcefully exhale after taking the deepest breath possible
Time frame: 6 week
Peak expiratory flow rate (PEFR) measures the maximum speed of air that a person can forcefully exhale in one breath
Time frame: 6 week
The Asthma Control Test (ACT) is scored by assigning a value from 1 to 5 to each response in the 5-question survey, then summing these values for a total score ranging from 5 to 25. A higher score indicates better asthma control. A score of 20 or higher generally suggests well-controlled asthma.
Time frame: 6 week
The Standardized Asthma Quality of Life Questionnaire (AQLQ(S)) is a 32-item questionnaire used to assess the impact of asthma on an individual's quality of life, specifically focusing on the physical, emotional, and social aspects. 7-point Likert scale (7 = not impaired at all - 1 = severely impaired). Scores range 1-7, with higher scores indicating better quality of life.
Contact information is provided by the study sponsor or research team.
Riphah International University
Other
Comparison of Effects of Alternate Nostril Breathing Exercise With Incentive Spirometer Technique on Lung Functions Among Asthma Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00341237
Asthma, Bronchial Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07219173
Asthma, Bronchial Diseases
Tempe, Arizona, United States
View Trial DetailsNCT07228052
Asthma, Bronchial Diseases
The Bronx, New York, United States
View Trial DetailsNCT07556159
Asthma, Bronchial Diseases
Chandler, Arizona, United States
View Trial Details